Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T70319 |
ANT431
|
||
ANT431 is a novel metallo-β-lactamase inhibitor for the treatment of carbapenem-resistant enterobacteriaceae infections | |||
T70318 |
AMG-337 monohydrate
|
||
AMG-337 monohydrate is a highly selective small molecule MET inhibitor. Aberrant hepatocyte growth factor (HGF)/MET signaling has been implicated in hepatocarcinogenesis, suggesting that MET may serve as an attractive therapeutic target in hepatocellular carcinoma. |